Other languages Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Market Closed - Nyse Other stock markets 04:00:02 2024-07-02 pm EDT			5-day change	1st Jan Change
91.23 ^USD	+1.09%		+0.16%	+19.65%

Jul. 02	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating	MT
Jun. 20	Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	Jun. 20
Edwards Lifesciences Corporation Announces Executive Changes	Jun. 17
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	Jun. 05
Sector Update: Health Care Stocks Steady Premarket Monday	Jun. 03
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	Jun. 03
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	Jun. 03
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	Jun. 03
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	Jun. 03
EE.UU. - Valores a seguir en Wall Street (actualizado)	May. 31
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	May. 13
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	May. 13
Edwards Lifesciences hit with Meril's EU antitrust complaint	May. 13
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor	May. 09
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	May. 09
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	May. 08
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	May. 01
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	Apr. 30
Alphabet : ExxonMobil, Microsoft...les valeurs à suivre aujourd'hui à Wall Street	Apr. 26
STATI UNITI. - I titoli da tenere d'occhio a Wall Street	Apr. 26
EE.UU. - Valores a seguir en Wall Street	Apr. 26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT